Shiga Toxin–ProducingEscherichia coliInfections Associated with Hemolytic Uremic Syndrome, Italy, 1988–2000

• DOI: 10.3201/eid0901.020266
• Publication Date: 2012-06-22T19:41:27Z
• Authors: Alberto E. Tozzi; Alfredo Caprioli; Fabio Minelli; Alessandra Gianviti; Laura De Petris; Alberto Edefonti; Giovanni Montini; Alfonso Ferretti; Tommaso De Palo; Maurizio Gaido; Gianfranco Rizzoni
• Keywords: 0301 basic medicine; Adolescent; Infectious and parasitic diseases; RC109-216; Escherichia coli O157; Shiga Toxin; 03 medical and health sciences; Shiga toxin-producing Escherichia coli; Escherichia coli; Humans; HUS; Serotyping; laboratory diagnosis; Escherichia coli Infections; surveillance; childhood; outbreak; children; Research; Incidence; R; 3. Good health; STEC; Italy; Child, Preschool; Population Surveillance; Hemolytic-Uremic Syndrome; hemolytic uremic syndrome; Medicine; epidemiology

Abstract The mean annual incidence of hemolytic uremic syndrome in persons <15 years age Italy from 1988 to 2000 was 0.28 per 100,000 population. Laboratory investigations showed that Shiga toxin–producing Escherichia coli (STEC) infection occurred 73.1% patients. STEC O157 the most common serotype, but a considerable number cases were infections by non-O157 STEC.